查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1721212

中风治疗市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Stroke Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 165 Pages | 商品交期: 2-10个工作天内

价格

中风治疗市场-报告范围

TMR 关于全球中风治疗市场的报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2019 年至 2035 年期间全球中风治疗市场的收入，以 2025 年为基准年，2035 年为预测年。报告中也提供了2025年至2035年全球中风治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初步研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了访谈。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解中风治疗市场。

市场概况
2024 年的市场价值 39亿美元
2035年的市场价值 94亿美元
复合年增长率 8.4%

该报告深入探讨了全球中风治疗市场的竞争格局。我们已经确定了在全球中风治疗市场中运作的关键参与者，并根据各种属性对每位参与者进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告介绍的全球中风治疗市场参与者的属性。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球中风治疗市场分析与预测

第五章：关键见解

  • 重要产业活动
  • PESTEL分析
  • 主要国家/地区监管情况
  • 波特五力分析
  • 产品/品牌分析
  • 供应链分析
  • 管道分析

第六章：全球市场分析与预测：依类型

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按类型，2020-2035
    • 缺血性中风
      • 血栓性中风
      • 栓塞性中风
    • 出血性中风
      • 脑出血
      • 蜘蛛网膜下腔出血
  • 市场吸引力分析：按类型

第七章：全球市场分析与预测：依药品类别

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：依药物类别，2020-2035
    • 抗凝血剂
    • 抗血小板
    • 组织纤溶酶原激活剂（tPA）
    • 他汀类药物
    • β受体阻断剂
    • 其他的
  • 市场吸引力分析：依药品类别

第八章：全球市场分析与预测：依管理途径

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：依给药途径，2020-2035
    • 口服
    • 肠外
  • 市场吸引力分析：按给药途径

第九章：全球市场分析与预测：依药品供应状况

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按药物可用性，2020-2035
    • 品牌
    • 通用的
  • 市场吸引力分析：依药品供应情况

第十章：全球市场分析与预测：按配销通路

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2020-2035
    • 医院药房
    • 零售药局
    • 网路药局
  • 市场吸引力分析：按配销通路

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2035
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第十二章：北美市场分析与预测

第十三章：欧洲市场分析与预测

第十四章：亚太市场分析与预测

第十五章：拉丁美洲市场分析与预测

第十六章：中东和非洲市场分析与预测

第 17 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2024年）
  • 公司简介
    • Bristol-Myers Squibb Company
    • Sanofi
    • F. Hoffmann-La Roche (Genentech)
    • Daiichi Sankyo Company, Limited
    • AstraZeneca
    • Biogen Inc.
    • Johnson & Johnson Services, Inc.
    • Bayer AG
    • Eli Lilly and Company
    • Mylan
    • Teva Pharmaceuticals
    • Zydus Cadila
    • Sun Pharmaceutical
Product Code: TMRGL73917

Stroke Treatment Market - Scope of Report

TMR's report on the global stroke treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global stroke treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stroke treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the stroke treatment market.

Market Snapshot
Market Value in 2024US$ 3.9 Bn
Market Value in 2035US$ 9.4 Bn
CAGR8.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stroke treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stroke treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stroke treatment market.

The report delves into the competitive landscape of the global stroke treatment market. Key players operating in the global stroke treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stroke treatment market profiled in this report.

Key Questions Answered in Global stroke treatment Market Report:

  • What is the sales/revenue generated by stroke treatment across all regions during the forecast period?
  • What are the opportunities in the global stroke treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Stroke Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global stroke treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global stroke treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stroke treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Stroke Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Stroke Treatment Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. PESTEL Analysis
  • 5.3. Regulatory Scenario by Key Countries/Regions
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. Product/Brand Analysis
  • 5.6. Supply Chain Analysis
  • 5.7. Pipeline Analysis

6. Global Stroke Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020-2035
    • 6.3.1. Ischemic Stroke
      • 6.3.1.1. Thrombotic Stroke
      • 6.3.1.2. Embolic Stroke
    • 6.3.2. Hemorrhagic Stroke
      • 6.3.2.1. Intracerebral Hemorrhage
      • 6.3.2.2. Subarachnoid Hemorrhage
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Stroke Treatment Market Analysis and Forecast, by Drug Class

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug Class, 2020-2035
    • 7.3.1. Anticoagulants
    • 7.3.2. Antiplatelets
    • 7.3.3. Tissue plasminogen activator (tPA)
    • 7.3.4. Statins
    • 7.3.5. Beta-Blockers
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Drug Class

8. Global Stroke Treatment Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2020-2035
    • 8.3.1. Oral
    • 8.3.2. Parenteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Stroke Treatment Market Analysis and Forecast, by Drug Availability

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Drug Availability, 2020-2035
    • 9.3.1. Branded
    • 9.3.2. Generic
  • 9.4. Market Attractiveness Analysis, by Drug Availability

10. Global Stroke Treatment Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2020-2035
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Stroke Treatment Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2020-2035
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Stroke Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020-2035
    • 12.2.1. Ischemic Stroke
      • 12.2.1.1. Thrombotic Stroke
      • 12.2.1.2. Embolic Stroke
    • 12.2.2. Hemorrhagic Stroke
      • 12.2.2.1. Intracerebral Hemorrhage
      • 12.2.2.2. Subarachnoid Hemorrhage
  • 12.3. Market Value Forecast, by Drug Class, 2020-2035
    • 12.3.1. Anticoagulants
    • 12.3.2. Antiplatelets
    • 12.3.3. Tissue plasminogen activator (tPA)
    • 12.3.4. Statins
    • 12.3.5. Beta-Blockers
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 12.4.1. Oral
    • 12.4.2. Parenteral
  • 12.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 12.5.1. Branded
    • 12.5.2. Generic
  • 12.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 12.6.1. Hospital Pharmacies
    • 12.6.2. Retail Pharmacies
    • 12.6.3. Online Pharmacies
  • 12.7. Market Value Forecast, by Country, 2020-2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Type
    • 12.8.2. By Drug Class
    • 12.8.3. By Route of Administration
    • 12.8.4. By Drug Availability
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Stroke Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020-2035
    • 13.2.1. Ischemic Stroke
      • 13.2.1.1. Thrombotic Stroke
      • 13.2.1.2. Embolic Stroke
    • 13.2.2. Hemorrhagic Stroke
      • 13.2.2.1. Intracerebral Hemorrhage
      • 13.2.2.2. Subarachnoid Hemorrhage
  • 13.3. Market Value Forecast, by Drug Class, 2020-2035
    • 13.3.1. Anticoagulants
    • 13.3.2. Antiplatelets
    • 13.3.3. Tissue plasminogen activator (tPA)
    • 13.3.4. Statins
    • 13.3.5. Beta-Blockers
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 13.4.1. Oral
    • 13.4.2. Parenteral
  • 13.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 13.5.1. Branded
    • 13.5.2. Generic
  • 13.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 13.6.1. Hospital Pharmacies
    • 13.6.2. Retail Pharmacies
    • 13.6.3. Online Pharmacies
  • 13.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.7.1. Germany
    • 13.7.2. UK
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Type
    • 13.8.2. By Drug Class
    • 13.8.3. By Route of Administration
    • 13.8.4. By Drug Availability
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Stroke Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020-2035
    • 14.2.1. Ischemic Stroke
      • 14.2.1.1. Thrombotic Stroke
      • 14.2.1.2. Embolic Stroke
    • 14.2.2. Hemorrhagic Stroke
      • 14.2.2.1. Intracerebral Hemorrhage
      • 14.2.2.2. Subarachnoid Hemorrhage
  • 14.3. Market Value Forecast, by Drug Class, 2020-2035
    • 14.3.1. Anticoagulants
    • 14.3.2. Antiplatelets
    • 14.3.3. Tissue plasminogen activator (tPA)
    • 14.3.4. Statins
    • 14.3.5. Beta-Blockers
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 14.4.1. Oral
    • 14.4.2. Parenteral
  • 14.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 14.5.1. Branded
    • 14.5.2. Generic
  • 14.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 14.6.1. Hospital Pharmacies
    • 14.6.2. Retail Pharmacies
    • 14.6.3. Online Pharmacies
  • 14.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Type
    • 14.8.2. By Drug Class
    • 14.8.3. By Route of Administration
    • 14.8.4. By Drug Availability
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Stroke Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2020-2035
    • 15.2.1. Ischemic Stroke
      • 15.2.1.1. Thrombotic Stroke
      • 15.2.1.2. Embolic Stroke
    • 15.2.2. Hemorrhagic Stroke
      • 15.2.2.1. Intracerebral Hemorrhage
      • 15.2.2.2. Subarachnoid Hemorrhage
  • 15.3. Market Value Forecast, by Drug Class, 2020-2035
    • 15.3.1. Anticoagulants
    • 15.3.2. Antiplatelets
    • 15.3.3. Tissue plasminogen activator (tPA)
    • 15.3.4. Statins
    • 15.3.5. Beta-Blockers
    • 15.3.6. Others
  • 15.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 15.4.1. Oral
    • 15.4.2. Parenteral
  • 15.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 15.5.1. Branded
    • 15.5.2. Generic
  • 15.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 15.6.1. Hospital Pharmacies
    • 15.6.2. Retail Pharmacies
    • 15.6.3. Online Pharmacies
  • 15.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Type
    • 15.8.2. By Drug Class
    • 15.8.3. By Route of Administration
    • 15.8.4. By Drug Availability
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Stroke Treatment Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Type, 2020-2035
    • 16.2.1. Ischemic Stroke
      • 16.2.1.1. Thrombotic Stroke
      • 16.2.1.2. Embolic Stroke
    • 16.2.2. Hemorrhagic Stroke
      • 16.2.2.1. Intracerebral Hemorrhage
      • 16.2.2.2. Subarachnoid Hemorrhage
  • 16.3. Market Value Forecast, by Drug Class, 2020-2035
    • 16.3.1. Anticoagulants
    • 16.3.2. Antiplatelets
    • 16.3.3. Tissue plasminogen activator (tPA)
    • 16.3.4. Statins
    • 16.3.5. Beta-Blockers
    • 16.3.6. Others
  • 16.4. Market Value Forecast, by Route of Administration, 2020-2035
    • 16.4.1. Oral
    • 16.4.2. Parenteral
  • 16.5. Market Value Forecast, by Drug Availability, 2020-2035
    • 16.5.1. Branded
    • 16.5.2. Generic
  • 16.6. Market Value Forecast, by Distribution Channel, 2020-2035
    • 16.6.1. Hospital Pharmacies
    • 16.6.2. Retail Pharmacies
    • 16.6.3. Online Pharmacies
  • 16.7. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Type
    • 16.8.2. By Drug Class
    • 16.8.3. By Route of Administration
    • 16.8.4. By Drug Availability
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. Bristol-Myers Squibb Company
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Sanofi
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. F. Hoffmann-La Roche (Genentech)
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Daiichi Sankyo Company, Limited
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. AstraZeneca
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Biogen Inc.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Johnson & Johnson Services, Inc.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Bayer AG
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Eli Lilly and Company
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Mylan
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Teva Pharmaceuticals
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. Zydus Cadila
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. Sun Pharmaceutical
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments

List of Tables

  • Table 01: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 02: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 03: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 04: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 05: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 06: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 07: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 08: Global Stroke Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 09: North America - Stroke Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 10: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 11: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 12: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 13: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 14: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 15: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 16: North America - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 19: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 20: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 21: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 22: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 23: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 24: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 25: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 27: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 28: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 29: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 30: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 31: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 32: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 33: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 34: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 35: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 36: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 37: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 38: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 39: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 40: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 41: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 42: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Type, 2020-2035
  • Table 43: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Ischemic Stroke, 2020-2035
  • Table 44: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Hemorrhagic Stroke, 2020-2035
  • Table 45: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 46: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 47: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Drug Availability, 2020-2035
  • Table 48: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 03: Global Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 04: Global Stroke Treatment Market Revenue (US$ Bn), by Ischemic Stroke, 2020-2035
  • Figure 05: Global Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 06: Global Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 07: Global Stroke Treatment Market Revenue (US$ Bn), by Anticoagulants, 2020-2035
  • Figure 08: Global Stroke Treatment Market Revenue (US$ Bn), by Antiplatelets, 2020-2035
  • Figure 09: Global Stroke Treatment Market Revenue (US$ Bn), by Tissue plasminogen activator (tPA), 2020-2035
  • Figure 10: Global Stroke Treatment Market Revenue (US$ Bn), by Statins, 2020-2035
  • Figure 11: Global Stroke Treatment Market Revenue (US$ Bn), by Beta-Blockers, 2020-2035
  • Figure 12: Global Stroke Treatment Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 13: Global Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 14: Global Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 15: Global Stroke Treatment Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 16: Global Stroke Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035
  • Figure 17: Global Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 18: Global Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 19: Global Stroke Treatment Market Revenue (US$ Bn), by Branded, 2020-2035
  • Figure 20: Global Stroke Treatment Market Revenue (US$ Bn), by Generic, 2020-2035
  • Figure 21: Global Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 22: Global Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 23: Global Stroke Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 24: Global Stroke Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 25: Global Stroke Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035
  • Figure 26: Global Stroke Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 27: Global Stroke Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 28: North America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 29: North America - Stroke Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: North America - Stroke Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 31: North America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 32: North America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 33: North America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 34: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 35: North America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 36: North America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 37: North America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 38: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 39: North America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 40: North America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 41: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 42: Europe - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 43: Europe - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 44: Europe - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 45: Europe - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 46: Europe - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 47: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 48: Europe - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 49: Europe - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 50: Europe - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 51: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 52: Europe - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 53: Europe - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 54: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 55: Asia Pacific - Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 56: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 57: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 58: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 59: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 60: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 61: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 62: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 63: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 64: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 65: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 67: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 68: Latin America - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 69: Latin America - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 70: Latin America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 71: Latin America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 72: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 73: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 74: Latin America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 75: Latin America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 76: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 77: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 78: Latin America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 79: Latin America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 80: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 81: Middle East & Africa - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 82: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 83: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035
  • Figure 84: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035
  • Figure 85: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 86: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 87: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 88: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 89: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035
  • Figure 90: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035
  • Figure 91: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 92: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035